Endocare (endo) und Biolife Solution! - 500 Beiträge pro Seite

[can2]

Biolife Solution und Endocare (endo)

Biolife Solution noch kaum reagiert! Noch:0,15USD 27%
(WKN:894679)

Endocare:4,10USD 286%

Börse Nasdaq Other OTC

Aktuell 4,10 USD

Zeit 05.03.04 20:48

Diff. Vortag +286,79 %

Tages-Vol. 445.133,00

Geh. Stück 106.245

BINGHAMTON, N.Y., Mar 4, 2004 /PRNewswire-FirstCall via COMTEX/ -- BioLife Solutions Inc. (OTC Bulletin Board: BLFS) announced today the settlement of a dispute between the Company and Irvine, CA-based Endocare, Inc. (OTC: ENDO), arising out of Endocare`s failure to register stock delivered to BioLife as part of the transaction by which BioLife sold its cryosurgical equipment assets to Endocare on June 24, 2002. Under the settlement, Endocare will make a one- time payment to BioLife of $1.87 million.

BioLife President and CEO John G. Baust, Ph.D., said, "It is with great pleasure that we have settled our dispute with Endocare. This will allow the Company to pay outstanding loans, reduce its payables, and move forward with its business strategy. We continue to strive to expand our customer base and to position BioLife to derive growing revenue streams from a broader base of customers."

About BioLife Solutions, Inc.

[toothstone]

Hi can2,
hab mir mal zum Spaß ein paar geholt. Aber bei Endo hab ich einen
komplett anderen Kursverlauf von 4 auf 4,1 , nicht 286%.
Chartverlauf von Bigchart
Bleibt meines Erachten trotzdem spannend.

[can2]

Börse Nasdaq Other OTC

Aktuell 4,15 USD

Zeit 05.03.04 21:40

Diff. Vortag +291,51 %

Tages-Vol. 454.628,00

Geh. Stück 108.545


merkwürdig? Biolife Solutions oder Endocare gekauft? Was sagst Du zu den News? Biolife S. ist doch noch völlig unterbewertet? 2 Mio Marktkapitalisierung recht gering?

[toothstone]

Das mit Endo muß wohl ein Fehler sein, auch Consorskurse und chart
sagen was anderes. News hören sich gut an, bin abersicher kein Profi,
der das deuten kann. Die Tagesentwicklung gefällt mir dafür umso besser. Ich werde auch noch vorsichtig aufstocken.
Vielleicht muß man doch bei dlgi raus, sehr ungern, hatte sie zu
0,38, 0,43, 0,47 gekauft. auch mal ein Treffer.
Haste dir mal Ambient angeschaut, sieht ähnlich aus.

[can2]

Ambient: Tief:0,065, aber schon gut zugelegt das Teil!

Börse NASDAQ OTC BBS

Aktuell 0,44 USD

Zeit 05.03.04 21:59

Diff. Vortag +7,32 %

Tages-Vol. 9,26 Mio.

Geh. Stück 23 Mio.



Geld 0,44

Brief 0,45

Zeit 05.03.04 21:59

Spread 2,22%

Geld Stk. 5.000

Brief Stk. 5.000



Schluss
Vortag 0,41

Eröffnung 0,38

Hoch 0,483

Tief 0,359

52W Hoch 0,41

52W Tief 0,065


Biosolutions werde ich mal länger halten, der biotrend ist da!

[can2]

bin mal die nächsten tage gespannt!

Last Sale: 0.16 +0.05 +45.45% Company Profile

Volume: 78,040 Previous Close: 0.11 (3/5/2004)
03:58:04 PM 3/05/2004


Today`s High: 0.16

Today`s Low: 0.14
Best Bid: 0.16 Best Ask: 0.2



Share Data

Authorized Outstanding
Date Shares Source Date Shares Source
08/14/2003 25,000,000 10QSB 11/12/2003 12,413,209

Market News
--------------------------------------------------------------------------------
BLFS BIOLIFE SOLUTIONS INC
ENDO ENDOCARE INC
--------------------------------------------------------------------------------

BioLife Solutions Settles Dispute With Endocare

THURSDAY , MARCH 04, 2004 01:30 AM

BINGHAMTON, N.Y., Mar 4, 2004 /PRNewswire-FirstCall via COMTEX/ -- BioLife Solutions Inc. (OTC Bulletin Board: BLFS) announced today the settlement of a dispute between the Company and Irvine, CA-based Endocare, Inc. (OTC: ENDO), arising out of Endocare`s failure to register stock delivered to BioLife as part of the transaction by which BioLife sold its cryosurgical equipment assets to Endocare on June 24, 2002. Under the settlement, Endocare will make a one- time payment to BioLife of $1.87 million.

BioLife President and CEO John G. Baust, Ph.D., said, "It is with great pleasure that we have settled our dispute with Endocare. This will allow the Company to pay outstanding loans, reduce its payables, and move forward with its business strategy. We continue to strive to expand our customer base and to position BioLife to derive growing revenue streams from a broader base of customers."

About BioLife Solutions, Inc.

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on the Company`s proprietary bio-packaging technology and a patented under-standing of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. The expanding practice of cell and gene therapy has created a need for products that ensure the biological viability of mammalian cell and tissue material during transportation and storage. The HypoThermosol(R) and CryoStor(TM) products that the Company is selling today are a significant step forward in meeting these needs.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact. Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions` actual results to differ materially are discussed in the Company`s recent filings with the Securities and Exchange Commission. BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

For further information, please contact: investors, Jill Bertotti , [e-mail] or media, Len Hall, [e-mail] , both of Allen & Caron Inc, [phone], for BioLife Solutions Inc.

SOURCE BioLife Solutions Inc.

Was meint Ihr? Über rege diskussionen und Informationen wäre ich dankbar.